MPM BioVentures 2014, L.P. - Insider Trading & Ownership

Location
C/O Mpm Bioimpact, 399 Boylston Street, Suite 1100, Boston, MA
Summary
The estimated value of insider holdings of MPM BioVentures 2014, L.P. is at least $109M dollars as of May 15, 2025. MPM BioVentures 2014, L.P. is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $88.6M. MPM BioVentures 2014, L.P. is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $17M. MPM BioVentures 2014, L.P. is the 10%+ Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $3.37M.
Signature
/s/ Ansbert Gadicke, Managing Director of MPM BioVentures 2014 LLC, the Managing Member of MPM BioVentures 2014 GP LLC, the General Partner of MPM BioVentures 2014, L.P.
All Insider Reports
All Insider Reports

Ownership of MPM BioVentures 2014, L.P.

Insider Transactions Reported by MPM BioVentures 2014, L.P.:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.